Financhill
Buy
56

PTGX Quote, Financials, Valuation and Earnings

Last price:
$49.55
Seasonality move :
13.71%
Day range:
$50.72 - $53.58
52-week range:
$24.22 - $60.60
Dividend yield:
0%
P/E ratio:
12.15x
P/S ratio:
7.44x
P/B ratio:
4.64x
Volume:
790.4K
Avg. volume:
1.4M
1-year change:
83.04%
Market cap:
$3.1B
Revenue:
$434.4M
EPS (TTM):
$4.20

Earnings Data

Next earnings date for PTGX
May 07
2025
Most recent earnings per share
$1.98
Beat by $1.73
(Feb 21/2025)
Consensus Estimate
$0.25
(Feb 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PTGX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/07/2025 Q1 $30.4M -- -- $0.11 --
02/21/2025 Q4 $56.6M $170.6M $1.98 $0.25 $1.73
11/07/2024 Q3 $1.8M $4.7M -$0.54 -$0.53 -$0.01
08/06/2024 Q2 $6.7M $4.2M -$0.50 -$0.41 -$0.09
05/07/2024 Q1 $120M $255M $3.26 $1.60 $1.66
02/27/2024 Q4 $30M $60M $0.44 -$0.18 $0.62
11/02/2023 Q3 -- -- -$0.58 -$0.70 $0.12
08/03/2023 Q2 -- -- -$0.68 -$0.66 -$0.02
05/04/2023 Q1 -- -- -$0.67 -$0.70 $0.03
03/15/2023 Q4 -- -- -$0.69 -$0.61 -$0.08
11/08/2022 Q3 -- -- -$0.64 -$0.82 $0.18
08/04/2022 Q2 -- -- -$0.84 -$0.98 $0.14
05/04/2022 Q1 -- -- -$0.43 -$0.60 $0.17
02/28/2022 Q4 -- -- -$0.77 -$0.76 -$0.01
11/03/2021 Q3 -- -- -$0.70 -$0.66 -$0.04
08/04/2021 Q2 -- -- -$0.69 -$0.53 -$0.16
05/04/2021 Q1 -- -- -$0.54 -$0.57 $0.02
03/10/2021 Q4 -- -- -$0.48 -$0.47 -$0.01
11/04/2020 Q3 -- -- -$0.21 -$0.56 $0.35
08/06/2020 Q2 -- -- -$0.59 -$0.59 -$0.01
05/07/2020 Q1 -- -- -$0.72 -$0.68 -$0.04
03/10/2020 Q4 -- -- -$0.63 -$0.70 $0.07
11/06/2019 Q3 -- -- -$0.61 -$0.73 $0.12
08/07/2019 Q2 -- -- -$1.18 -$0.27 -$0.91
05/08/2019 Q1 -- -- -$0.58 -$0.63 $0.05
03/12/2019 Q4 -- -- -$0.57 -$0.47 -$0.10
11/06/2018 Q3 -- -- -$0.38 -$0.33 -$0.05
08/07/2018 Q2 -- -- -$0.41 -$0.29 -$0.12
05/09/2018 Q1 -- -- -$0.36 -$0.24 -$0.12
03/07/2018 Q4 -- -- -$0.15 -$0.37 $0.22
11/06/2017 Q3 -- -- -$0.29 -$0.61 $0.32
08/08/2017 Q2 -- -- -$0.89 -$0.81 -$0.08
03/31/2017 Q1 -- -- -$0.84 -$0.60 -$0.25

Protagonist Therapeutics Earnings Questions

  • How Much did Protagonist Therapeutics Generate in Revenue Last Quarter?

    Protagonist Therapeutics reported $170.6M worth of top line sales in its most recent quarter.

  • Did Protagonist Therapeutics Beat Earnings Last Quarter?

    Protagonist Therapeutics announced earnings per share of $1.98 which represents a beat of analyst forecast a $0.25 per share.

  • Is Protagonist Therapeutics Profitable?

    Protagonist Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Protagonist Therapeutics EPS Next Year?

    Protagonist Therapeutics's earnings are forecast to decrease from $4.23 per share to $2.63 per share next year representing a decrease of -59.85%.

  • When is Protagonist Therapeutics's Earnings Date?

    Protagonist Therapeutics's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Diamondback Energy a Good Stock to Buy?
Is Diamondback Energy a Good Stock to Buy?

Diamondback Energy (FANG) is a lesser-known diamond in the rough…

What Is Hindsight Bias In Investing?
What Is Hindsight Bias In Investing?

You’ve probably heard the expression “hindsight is 20/20.” That saying…

Is Rivian a Good Stock a Buy?
Is Rivian a Good Stock a Buy?

Rivian Automotive (RIVN) had an initial IPO of close to…

Stock Ideas

Buy
58
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Sell
29
UNF alert for Mar 26

UniFirst [UNF] is up 0.24% over the past day.

Sell
30
KEQU alert for Mar 26

Kewaunee Scientific [KEQU] is down 1.45% over the past day.

Buy
82
EPAC alert for Mar 26

Enerpac Tool Group [EPAC] is down 3.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock